HOW WE WORK
iO‑CO runs a venture building model founded on scientific discovery, IP creation, and scalable execution
Every idea moves through a defined pathway, ensuring that insight becomes impact, not just innovation:
01
Research
02
Product concept
03
Prototyping
04
Validation
05
Commercialisation
WE DON'T LEAVE INNOVATION TO CHANCE
A system built to scale innovation
iO‑CO operates a high-performance, stage-gated system designed to transform original insight into defensible, scalable ventures – reliably, repeatedly, and with reduced risk. Each phase adds value, reduces risk, and strengthens IP, creating a venture engine built for continuous innovation.
DISCOVERY PIPELINE
Insight before execution
Our discovery pipeline casts a wide net across neuroscience, microbiology, psychophysiology, and sensory health.
We cross-reference behavioural insights with:
01
02
03
04
Emerging academic research and early-stage findings
Biological mechanisms with clear therapeutic potential
Policy shifts and macro health trends
Innovation whitespace for original, protectable IP
Only when human, biological, commercial, and scientific signals align do we begin building.
WHERE WE ARE
Our dual-base model for innovation
iO‑CO operates from two complementary bases: Ascot, UK, and Jersey, Channel Islands.
In Ascot, our core R&D team transforms scientific insight into proof of concept through ideation, prototyping, industrial design, and in-house testing.
In Jersey, our high-performance lab bridges science and experience. The island’s unique scale allows us to test and refine innovations with real users in real environments, validating impact before commercial launch.
Together, these sites form a closed loop between discovery and validation, accelerating the path from concept to market.
DISCOVER WHAT WE ARE BUILDING
Learn more about iO‑CO’s portfolio of spinout ventures and our evolving R&D pipeline
